The Genomic Landscape of Juvenile Myelomonocytic Leukemia
Biomarkers (4)
- Absolute_Monocyte_Count - Blood absolute monocyte count (phv00253303.v1.p1)
- Fetal_hemoglobin - Fetal hemoglobin levels (phv00253305.v1.p1)
- Platelets - Blood platelet count (phv00253304.v1.p1)
- White_Blood_Count - White blood count (phv00253302.v1.p1)
Demographics (2)
- Age_months - Age of patient in number of months (phv00253301.v1.p1)
- Gender - Participant's gender as Male or Female (phv00252933.v1.p1)
Other (18)
- ANALYTE_Type - Molecular analyte (phv00252938.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00252928.v1.p1)
- Hepatomegaly - Did the patient prensent with an abnomal enlargement of the liver? (phv00253308.v1.p1)
- Monosomy_7 - Is the patient missing a copy of chromosome 7? (phv00253306.v1.p1)
- Outcome - The patient outcome as it relates to the treatment (phv00253310.v1.p1)
- Primary Disease - Primary disease of patient (phv00252934.v1.p1)
- SAMPID - De-identified Sample ID (phv00252935.v1.p1)
- SAMPID - Sample ID (phv00252930.v1.p1)
- Sample Origin - Differentiates tumor and normal sample origin from patient (phv00252937.v1.p1)
- Sample Type - Indicates the Tumor / Normal status of a sample (phv00252936.v1.p1)
- SAMPLE_USE - Sample use type. Seq_DNA_SNP_MAF_Ind: Sample(s) were used to generate aggregate mutation annotation file (.maf) with individual SNP genotypes; Seq_DNA_WholeExome: Whole exome sequencing (phv00252931.v1.p1)
- Splenomegaly - Did the patient prensent with an abnomal enlargement of the spleen? (phv00253307.v1.p1)
- Status - Status of patient at the time of study (phv00253311.v1.p1)
- SUBJID - Unique Participant Identifier (phv00252932.v1.p1)
- SUBJID - Subject ID (phv00252929.v1.p1)
- SUBJID - Subject ID (phv00252927.v1.p1)
- Tissue_Type - The tissue type of the sample (phv00253312.v1.p1)
- Treatment - The patient treatment (phv00253309.v1.p1)